SIA
GILD icon

Stancorp Investment Advisers’s Gilead Sciences GILD Stock Holding History

Stancorp Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$628K Sell
6,398
-449
-7% -$45.6K 0.3% 96
2014
Q4 		$645K Buy
+6,847
New +$708K 0.3% 99

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Stancorp Investment Advisers's GILD Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its Gilead Sciences (GILD) stake by 6.6% in Q1 2015, selling an estimated $45.6K and leaving 6,398 shares worth $628K. The position accounts for 0.3% of the portfolio, ranked #96.

Stancorp Investment Advisers first reported a position in GILD in Q4 2014 and has held it in 2 quarters since. The position peaked at $645K in Q4 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Stancorp Investment Advisers held 6,398 shares of Gilead Sciences worth $628K as of Q1 2015.
  • Stancorp Investment Advisers sold 449 Gilead Sciences shares in Q1 2015, an estimated $45.6K.
  • Gilead Sciences made up 0.3% of Stancorp Investment Advisers's portfolio in Q1 2015, its #96 holding.
  • Stancorp Investment Advisers first reported a position in Gilead Sciences in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's Gilead Sciences position peaked at $645K in Q4 2014.
  • 1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.